{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:37:38Z","timestamp":1780465058693,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T00:00:00Z","timestamp":1406332800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00467-014-2886-4","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T08:00:17Z","timestamp":1406275217000},"page":"1087-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biologics in renal transplantation"],"prefix":"10.1007","volume":"30","author":[{"given":"Ryszard","family":"Grenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,26]]},"reference":[{"key":"2886_CR1","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","volume":"351","author":"PF Halloran","year":"2004","unstructured":"Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Eng J Med 351:2715\u20132729","journal-title":"N Eng J Med"},{"issue":"1","key":"2886_CR2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.tmrv.2009.09.010","volume":"24","author":"N Shehata","year":"2010","unstructured":"Shehata N, Palda V, Meyer RM, Blydt-Hansen TD, Campbell P, Cardella C, Martin S, Nickerson P, Peltekian K, Ross H, Waddell TK, West L, Anderson D, Freedman J, Hume H (2010) The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline. Transfusion Med Rev 24(1):S7\u2013S27","journal-title":"Transfusion Med Rev"},{"key":"2886_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trre.2010.11.002","volume":"25","author":"SA Serres De","year":"2011","unstructured":"De Serres SA, Yeung M, Mfarrej B (2011) Najafian N (2011) Effect of biologic agents on regulatory T cells. Transplant Rev 25:110\u2013116","journal-title":"Transplant Rev"},{"issue":"4","key":"2886_CR4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5500\/wjt.v3.i4.68","volume":"3","author":"K Hardinger","year":"2013","unstructured":"Hardinger K, Brennan D (2013) Novel immunosuppressive drugs in kidney transplantation. World J Transplant 3(4):68\u201377","journal-title":"World J Transplant"},{"key":"2886_CR5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","volume":"10","author":"F Vincenti","year":"2010","unstructured":"Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP (2010) A phase III study of Belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT Study). Am J Transplant 10:535\u2013546","journal-title":"Am J Transplant"},{"key":"2886_CR6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","volume":"21","author":"F Vincenti","year":"2010","unstructured":"Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, M\u00fchlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B (2010) Five-Year Safety and Efficacy of Belatacept in Renal Transplantation. J Am Soc Nephrol 21:1587\u20131596","journal-title":"J Am Soc Nephrol"},{"key":"2886_CR7","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1600-6143.2009.02720.x","volume":"9","author":"S Busque","year":"2009","unstructured":"Busque S, Leventhal J, Brennan D, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G (2009) Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de-novo kidney allograft recipients. Am J Transplant 9:1936\u20131945","journal-title":"Am J Transplant"},{"key":"2886_CR8","unstructured":"Vincenti F, Yang H, Klintmalm G, Steinberg S, Wang L, Zhang W, Conkle A, Blahunka P, First R, Holman J (2013) Clinical outcomes in phase 1b, randomized double-blind, parallel, placebo-controlled, single-dose study of ASKP1240 in de novo kidney transplantation. Am J Transplant 13: S5, abstr 181"},{"key":"2886_CR9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/TP.0b013e3181a4b91b","volume":"87","author":"H Trivedi","year":"2009","unstructured":"Trivedi H, Terasaki P, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD (2009) Abrogation of anti-HLA antibodies via proteasome inhibition. Transplantation 87:1555\u20131556","journal-title":"Transplantation"},{"key":"2886_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","volume":"89","author":"R Walsh","year":"2010","unstructured":"Walsh R, Everly J, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES (2010) Proteasome-inhibitor based primary therapy for antibody-mediated renal allograft rejection. Transplantation 89:277\u2013284","journal-title":"Transplantation"},{"key":"2886_CR11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/TP.0b013e318188ae18","volume":"86","author":"B H\u00f6cker","year":"2008","unstructured":"H\u00f6cker B, Kovarik J, Daniel V, Opelz G, Fehrenbach H, Holder M, Hoppe B, Hoyer P, Jungraithmayr TC, K\u00f6pf-Shakib S, Laube GF, M\u00fcller-Wiefel DE, Offner G, Plank C, Schr\u00f6der M, Weber LT, Zimmerhackl LB, T\u00f6nshoff B (2008) Pharmacokinetics and immunodynamics of basiilximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation 86:1234\u20131240","journal-title":"Transplantation"},{"issue":"9","key":"2886_CR12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.TP.0000092950.54184.67","volume":"76","author":"MM Sarwal","year":"2003","unstructured":"Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 76(9):1331\u20131339","journal-title":"Transplantation"},{"key":"2886_CR13","unstructured":"Webster AC1, Ruster LP, McGee R, Matheson SL, Higgins GY, Willis NS, Chapman JR, Craig JC (2010) Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev 1:CD003897"},{"key":"2886_CR14","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1600-6143.2006.01367.x","volume":"6","author":"R Grenda","year":"2006","unstructured":"Grenda R, Watson A, Vondrak K, Webb NJ, Beattie J, Fitzpatrick M, Saleem MA, Trompeter R, Milford DV, Moghal NE, Hughes D, Perner F, Friman S, Van Damme-Lombaerts R, Janssen F (2006) A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant 6:1666\u20131672","journal-title":"Am J Transplant"},{"issue":"9","key":"2886_CR15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/TP.0b013e318188af15","volume":"86","author":"G Offner","year":"2008","unstructured":"Offner G, T\u00f6nshoff B, Hoecker B, Krauss M, Bulla M, Cochat P, Fehrenbach H, Fischer W, Foulard M, Hoppe B, Hoyer PF, Jungraithmayr TC, Klaus G, Latta K, Leichter H, Mihatsch MJ, Misselwitz J, Montoya C, M\u00fcller-Wiefel DE, Neuhaus TJ, Pape L, Querfeld U, Plank C, Schwarke D, Wygoda S, Zimmerhackl LB (2008) Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation 86(9):1241\u20131248","journal-title":"Transplantation"},{"key":"2886_CR16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","volume":"10","author":"R Grenda","year":"2010","unstructured":"Grenda R, Watson A, Trompeter R, T\u00f6nshoff B, Jaray J, Fitzpatrick M, Murer L, Vondrak K, Maxwell H, van Damme-Lombaerts R, Loirat C, Mor E, Cochat P, Milford DV, Brown M, Webb NJ (2010) A Randomized Trial to Assess the Impact of Early Steroid Withdrawal on Growth in Pediatric Renal Transplantation: The TWIST Study. Am J Transplant 10:828\u2013836","journal-title":"Am J Transplant"},{"issue":"12","key":"2886_CR17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00467-011-1934-6","volume":"26","author":"A Delucchi","year":"2011","unstructured":"Delucchi A, Valenzuela M, Lillo A, Lillo AM, Guerrero JL, Cano F, Azocar M, Zambrano P, Salas P, Pinto V, Ferrario M, Rodr\u00edguez J, Cavada G (2011) Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol 26(12):2235\u20132244","journal-title":"Pediatr Nephrol"},{"key":"2886_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-6143.2009.02767.x","volume":"10","author":"MR Benfield","year":"2010","unstructured":"Benfield MR, Bartosh S, Ikle D, Warshaw B, Bridges N, Morrison Y, Harmon W (2010) A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant 10:81\u201388","journal-title":"Am J Transplant"},{"key":"2886_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1432-2277.2004.00003.x","volume":"18","author":"G Montini","year":"2005","unstructured":"Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G (2005) One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipients. Transplant Int 18:36\u201342","journal-title":"Transplant Int"},{"issue":"11","key":"2886_CR20","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00467-012-2391-6","volume":"28","author":"R Grenda","year":"2013","unstructured":"Grenda R (2013) Steroid withdrawal in renal transplantation. Pediatr Nephrol 28(11):2107\u20132112","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2886_CR21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/TP.0b013e3182295bed","volume":"92","author":"L Pape","year":"2011","unstructured":"Pape L, Lehner F, Blume C, Ahlenstiel T (2011) Pediatric kidney transplantation by de novo therapy with everolimus, low-dose cyclosporine A and steroid elimination: 3-year data. Transplantation 92(6):658\u2013662","journal-title":"Transplantation"},{"issue":"6","key":"2886_CR22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jpeds.2006.01.008","volume":"148","author":"E Shapiro","year":"2006","unstructured":"Shapiro E, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, Khan AS, Gray EA, Zeevi A, McFeaters C, James G, Jo Grosso M, Marcos A, Starzl TE (2006) Antilimphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 148(6):813\u2013818","journal-title":"J Pediatr"},{"issue":"12","key":"2886_CR23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/TP.0b013e3181903da7","volume":"86","author":"HP Tan","year":"2008","unstructured":"Tan HP, Donaldson J, Ellis D, Moritz ML, Basu A, Morgan C, Vats AN, Erkan E, Shapiro R (2008) Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4\u00a0years experience. Transplantation 86(12):1725\u20131731","journal-title":"Transplantation"},{"issue":"5","key":"2886_CR24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","volume":"14","author":"A Kirk","year":"2014","unstructured":"Kirk A, Guasch A, Xu H, Cheeseman J, Mead SI, Ghali A, Mehta AK, Wu D, Gebel H, Bray R, Horan J, Kean LS, Larsen CP, Pearson TC (2014) Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. Am J Transplant 14(5):1142\u20131151","journal-title":"Am J Transplant"},{"key":"2886_CR25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.TP.0000158325.12837.A2","volume":"79","author":"S Khositseth","year":"2005","unstructured":"Khositseth S, Matas A, Cook M, Bilingham K, Chavers B (2005) Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplantation recipients: a single center report. Transplantation 79:958\u2013963","journal-title":"Transplantation"},{"key":"2886_CR26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.tp.0000281907.54832.cb","volume":"84","author":"J Schwartz","year":"2007","unstructured":"Schwartz J, Ishitani M, Weckwerth J, Morgenstern B, Milliner D, Stegall MD (2007) Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation 84:715\u2013717","journal-title":"Transplantation"},{"key":"2886_CR27","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/TP.0b013e3181fc8937","volume":"90","author":"L Li","year":"2010","unstructured":"Li L, Chaudhuri A, Chen A, Zhao X, Bezchinsky M, Concepcion W, Salvatierra O Jr, Sarwal MM (2010) Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation 90:1516\u20131520","journal-title":"Transplantation"},{"issue":"2","key":"2886_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/TP.0b013e3181ac6833","volume":"88","author":"BM Chavers","year":"2009","unstructured":"Chavers BM, Chang C, Gillingham KJ, Matas A (2009) Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisolone: 2-year results. Transplantation 88(2):237\u2013241","journal-title":"Transplantation"},{"key":"2886_CR29","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","volume":"26","author":"G Mourad","year":"2012","unstructured":"Mourad G, Morelon E, No\u00ebl C, Glotz D, Lebranchu Y (2012) The role of Thymoglobulin induction in kidney transplantation: an update. Clin Transplant 26:E450\u2013E464","journal-title":"Clin Transplant"},{"key":"2886_CR30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/00007890-200205150-00025","volume":"73","author":"VR Peddi","year":"2002","unstructured":"Peddi VR, Bryant M, Roy-Chaudry P, Woddle ES, First MR (2002) Safety, efficacy and cost-analysis of Thymoglobuline induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation 73:1514\u20131508","journal-title":"Transplantation"},{"key":"2886_CR31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/TP.0b013e31825a7d1f","volume":"94","author":"OA Gaber","year":"2012","unstructured":"Gaber OA, Matas AJ, Henry ML, Brennan DC, Stevens RB, Kapur S, Ilsley JN, Kistler KD (2012) Cosimi AB: on behalf of the Thymoglobulin Antibody Immunosuppression in Living Donor Recipients Investigators (2012) Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients: Final Report of the TAILOR Registry. Transplantation 94:331\u2013337","journal-title":"Transplantation"},{"issue":"12","key":"2886_CR32","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1111\/j.1600-6143.2012.04278.x","volume":"12","author":"E Nehus","year":"2012","unstructured":"Nehus E, Goebel J, Abraham E (2012) Outcomes of steroid avoidance protocols in pediatric kidney transplant recipients. Am J Transplant 12(12):3441\u20133448","journal-title":"Am J Transplant"},{"issue":"3","key":"2886_CR33","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1111\/j.1399-0012.2012.01657.x","volume":"26","author":"V Nair","year":"2012","unstructured":"Nair V, Sawinski D, Akalin E, Friedlander R, Ebcioglu Z, Sehgal V, Dinavahi R, Khaim R, Ames S, Lerner S, Murphy B, Bromberg JS, Heeger PS (2012) Schr\u00f6ppel B (2012) Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates. Clin Transplant 26(3):E261\u2013E268","journal-title":"Clin Transplant"},{"issue":"1","key":"2886_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-3046.2006.00617.x","volume":"11","author":"RP Valentini","year":"2007","unstructured":"Valentini RP, Nehlsen-Cannarella SL, Gruber SA, Mattoo TK, West MS, Lang C, Imam AA (2007) Intravenous immunoglobulin, HLA allele typing and HLA Matchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. Pediatr Transplant 11(1):77\u201381","journal-title":"Pediatr Transplant"},{"key":"2886_CR35","doi-asserted-by":"crossref","unstructured":"Lobashevsky A, Higgins N, Rosner K, Mujtaba MA, Goggins WC, Taber TE (2013) Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximAb Transplantation 96:182\u2013190","DOI":"10.1097\/TP.0b013e3182962c84"},{"key":"2886_CR36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2215\/CJN.02940311","volume":"6","author":"J Garonzik Wang","year":"2011","unstructured":"Garonzik Wang J, Montgomery R, Kucirka L, Berger JC, Warren DS, Segev DL (2011) Incompatible live-donor kidney transplantation in United States: results of national survey. Clin J Am Soc Nephrol 6:2041\u20132046","journal-title":"Clin J Am Soc Nephrol"},{"key":"2886_CR37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","volume":"359","author":"A Vo","year":"2008","unstructured":"Vo A, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC (2008) Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Eng J Med 359:242\u2013251","journal-title":"N Eng J Med"},{"key":"2886_CR38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","volume":"9","author":"A Hariran","year":"2009","unstructured":"Hariran A, Nogueira J, Kukuruga D, Schweitzer E, Hess J, Gurk-Turner C, Jacobs S, Drachenberg C, Bartlett S, Cooper M (2009) Positive cross-match living donor kidney transplantation: longer-term outcome. Am J Transplant 9:536\u2013542","journal-title":"Am J Transplant"},{"issue":"9","key":"2886_CR39","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000262570.18117.55","volume":"83","author":"G Tyd\u00e9n","year":"2007","unstructured":"Tyd\u00e9n G, Donauer J, Wadstr\u00f6m J, Kumlien G, Wilpert J, Nilsson T, Genberg H, Pisarski P, Tufveson G (2007) Implementation of a protocol for AB0-incompatible kidney transplantation-a three-center experience with 60 consecutive transplantations. Transplantation 83(9):1153\u20131155","journal-title":"Transplantation"},{"key":"2886_CR40","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","volume":"11","author":"MD Stegall","year":"2011","unstructured":"Stegall MD, Diwan T, Raghvaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM (2011) Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 11:2405\u20132413","journal-title":"Am J Transplant"},{"key":"2886_CR41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TP.0b013e31824612df","volume":"93","author":"M Everly","year":"2012","unstructured":"Everly M, Terasaki P, Trivedi H (2012) Durability of antibody removal following proteasome inhibitor-based therapy. Transplantation 93:572\u2013577","journal-title":"Transplantation"},{"issue":"12","key":"2886_CR42","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","volume":"12","author":"J Zuber","year":"2012","unstructured":"Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, No\u00ebl LH, Hourmant M, Niaudet P, Fr\u00e9meaux-Bacchi V, Rondeau E, Legendre C, Loirat C, French Study Group for Atypical HUS (2012) French Study Group for Atypical HUS. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant 12(12):3337\u20133354","journal-title":"Am J Transplant"},{"issue":"3","key":"2886_CR43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/TP.0b013e3181aed9d7","volume":"88","author":"L Dello Strologo","year":"2009","unstructured":"Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L (2009) Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 88(3):417\u2013420","journal-title":"Transplantation"},{"key":"2886_CR44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00467-012-2314-6","volume":"28","author":"J Kumar","year":"2013","unstructured":"Kumar J, Shatat I, Skversky A, Woroniecki R, Del Rio M, Perelstein EM, Johnson VL, Mahesh S (2013) Rituximab in post-transplant pediatric recurrent focal segmental sclerosis. Pediatr Nephrol 28:333\u2013338","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2886_CR45","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1111\/j.1399-3046.2011.01519.x","volume":"16","author":"A Chaudhuri","year":"2012","unstructured":"Chaudhuri A, Kambham N, Sutherland S, Grimm P, Alexander S, Concepcion W, Sarwal M, Wong C (2012) Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type. Pediatr Transplant 16(5):E183\u2013187","journal-title":"Pediatr Transplant"},{"key":"2886_CR46","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/j.1600-6143.2008.02411.x","volume":"8","author":"V Zarkhin","year":"2008","unstructured":"Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal MM (2008) A randomized prospective trial of rituximab for acute rejection in pediatric transplantation. Am J Transplant 8:2607\u20132617","journal-title":"Am J Transplant"},{"key":"2886_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3046.2011.01615.x","volume":"16","author":"K Upadhyay","year":"2012","unstructured":"Upadhyay K, Midgley L, Mougdil A (2012) Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection. Pediatr Transplant 16:286\u2013293","journal-title":"Pediatr Transplant"},{"key":"2886_CR48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/TP.0b013e31819d3353","volume":"87","author":"M Clatworthy","year":"2009","unstructured":"Clatworthy M, Friend P, Calne R, Rebello PR, Hale G, Waldmann H, Watson CJ (2009) Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. Transplantation 87:1092\u20131095","journal-title":"Transplantation"},{"key":"2886_CR49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00467-011-1864-3","volume":"26","author":"B Kranz","year":"2011","unstructured":"Kranz B, Kelsch R, Kuwertz-Br\u00f6king E, Br\u00f6cker V, Wolters HH, Konrad M (2011) Acute antibody-mediated rejection in paediatric renal transplant recipients. Pediatr Nephrol 26:1149\u20131156","journal-title":"Pediatr Nephrol"},{"key":"2886_CR50","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-009-1386-4","volume":"25","author":"SC Jordan","year":"2010","unstructured":"Jordan SC, Reinmoen N, Peng A, Lai CH, Cao K, Villicana R, Toyoda M, Kahwaji J, Vo AA (2010) Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol 25:2035\u20132048","journal-title":"Pediatr Nephrol"},{"key":"2886_CR51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/ndt\/gfr465","volume":"27","author":"J Waiser","year":"2012","unstructured":"Waiser J, Budde K, Sch\u01dctz M (2012) Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. Nephrol Dial Transplant 27:1246\u20131251","journal-title":"Nephrol Dial Transplant"},{"key":"2886_CR52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","volume":"91","author":"RC Walsh","year":"2011","unstructured":"Walsh RC, Brailey P, Girnita A, Alloway RR, Shields AR, Wall GE, Sadaka BH, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy-Chaudhury P, Woodle ES (2011) Early and late acute antibody- mediated rejection differ in immunologically and in response to proteasome inhibition. Transplantation 91:1218\u20131226","journal-title":"Transplantation"},{"key":"2886_CR53","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/petr.12187","volume":"18","author":"G Ghirardo","year":"2014","unstructured":"Ghirardo G, Benetti E, Poli F, Vidal E, Della Vella M, Cozzi E, Murer L (2014) Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody. Pediatr Transplant 18:E1\u2013E5","journal-title":"Pediatr Transplant"},{"key":"2886_CR54","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","volume":"44","author":"F Gonzales-Roncero","year":"2012","unstructured":"Gonzales-Roncero F, Suner M, Bernal G, Cabello V, Toro M, Pereira P, Angel Gentil M (2012) Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports. Transplant Proc 44:2690\u20132694","journal-title":"Transplant Proc"},{"key":"2886_CR55","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","volume":"45","author":"B Kocak","year":"2013","unstructured":"Kocak B, Arpali E, Demiralp E, Yelken B, Karatas C, Gorcin S, Gorgulu N, Uzunalan M, Turkmen A, Kalayoglu M (2013) Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports. Transpl Proc 45:1022\u20131025","journal-title":"Transpl Proc"},{"key":"2886_CR56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181880b35","volume":"86","author":"H Billing","year":"2008","unstructured":"Billing H, Rieger S, Ovens J, S\u00fcsal C, Melk A, Waldherr R, Opelz G, T\u00f6nshoff B (2008) Successful treatment of chronic antibody mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 86:1214\u20131221","journal-title":"Transplantation"},{"key":"2886_CR57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1432-2277.2012.01544.x","volume":"25","author":"H Billing","year":"2012","unstructured":"Billing H, Rieger S, Susal C, Waldherr R, Opelz G, W\u00fchl E, T\u00f6nshoff B (2012) IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantion with 2-year follow-up. Transplant Int 25:1165\u20131173","journal-title":"Transplant Int"},{"key":"2886_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.trim.2013.08.003","volume":"29","author":"F Cicora","year":"2013","unstructured":"Cicora F, Paz M, Mos F, Roberti J (2013) Use of bortezomib in renal transplant recipients: a single-center experience. Transplant Immunol 29:7\u201310","journal-title":"Transplant Immunol"},{"key":"2886_CR59","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181b9692d","volume":"88","author":"G Opelz","year":"2009","unstructured":"Opelz G, Daniel V, Naukojat C, D\u00f6hler B (2009) Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 88:962\u2013967","journal-title":"Transplantation"},{"key":"2886_CR60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2003","unstructured":"Opelz G, D\u00f6hner B (2003) Lymphomas after solid organ transplantation: a Collaborative Transplant Study report. Am J Transplant 4:222\u2013230","journal-title":"Am J Transplant"},{"key":"2886_CR61","doi-asserted-by":"crossref","unstructured":"Kirk A, Cherikh W, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM (2007) Dissociation of depletional induction and post transplant lymphoproliferative disease in kidney recipients treated with alemtuzumAb Am J Transplant 7:2619\u20132625","DOI":"10.1111\/j.1600-6143.2007.01972.x"},{"key":"2886_CR62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-6143.2011.03893.x","volume":"12","author":"VR Dharnidharka","year":"2012","unstructured":"Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU (2012) Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant 12:976\u201383","journal-title":"Am J Transplant"},{"issue":"3","key":"2886_CR63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1600-6143.2006.01675.x","volume":"7","author":"DP Puliyanda","year":"2007","unstructured":"Puliyanda DP, Stablein DM, Dharnidharka VR (2007) Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant 7(3):662\u2013666","journal-title":"Am J Transplant"},{"issue":"5","key":"2886_CR64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.04051206","volume":"2","author":"JM Smith","year":"2007","unstructured":"Smith JM, Dhanidharka VR, Talley L, Martz K, McDonald RA (2007) BK virus nephropathy in pediatric renal transplant recipients: an analysis of North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2(5):1037\u20131042","journal-title":"Clin J Am Soc Nephrol"},{"key":"2886_CR65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-6143.2008.02499.x","volume":"9","author":"N Kamar","year":"2009","unstructured":"Kamar N, Mengelle C, Rostaing L (2009) Incidence of JC-Virus replication after rituximab therapy in solid-organ transplant patients. Am J Transplant 9:244\u2013245","journal-title":"Am J Transplant"},{"key":"2886_CR66","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ppul.20864","volume":"44","author":"M Bitzan","year":"2009","unstructured":"Bitzan M, Anselmo M, Carpineta L (2009) Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case report and systematic review of the literature. Pediatr Pulmonol 44:922\u2013934","journal-title":"Pediatr Pulmonol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2886-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2886-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2886-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T15:53:20Z","timestamp":1598111600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2886-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,26]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2886-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,26]]}}}